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Background: Earlier work suggests that fetal cardiac bypass is technically 
feasible but results in significant placental dysfunction. Many of the stimuli 
that initiate this placental dysfunction have been identified in the past 
several years and these involve fetal stress, extracorporeal surfaces, 
priming substances (maternal blood), and flow characteristics. Fetal 
survival with conventional methods of bypass has been far less than 
optimal. A novel fetal bypass circuit requiring no priming volume was 
designed incorporating an in,line axial flow pump (Hemopump, Johnson & 
Johnson Interventional Systems, Rancho Cordova, Calif.) and was demon- 
strated to have a marked beneficial effect on placental function. Objective: 
The purpose of this study was to investigate the effect of this newly 
developed customized fetal bypass circuit on fetal survival and developing 
fetal organs. Methods and results: Nine fetuses at 122 to 126 days of gestation 
were subjected to fetal cardiac bypass via a transsternal pproach, with a 
16F single right atrial venous cannula and a 12F arterial cannula. 
Normothermic cardiac bypass was continued for 30 minutes at flow rates of 
320 -+ 32 ml/kg. Of the nine fetuses, one fetus was stillborn 4 days after 
bypass and eight (89%) were delivered alive after progressing to term 
gestation. One lamb died of blunt trauma I day after birth. All other lambs 
(n = 7) thrived normally, and at 1 week of age they were subjected to 
autopsy. No gross hemorrhagic o r thromboembolic lesions were detected in 
the organs examined including the brain. Microscopic examination of 
representative s ctions from all organs revealed mild pleural reaction in 
two lambs, and in two other lambs the hepatocytes showed evidence of mild 
increase in glycogen content, the significance of which is unknown in 
relation to fetal bypass. In one fetus that was aborted there was evidence of 
mild to moderate neuronal oss in the cerebral cortex. Conclusion: This 
study demonstrates that with improvements in fetal extracorporeal cir- 
cuitry and techniques very favorable fetal outcome can be achieved. Further 
studies are necessary to evaluate the effects of bypass on fetal brain in an 
appropriate animal model. Advances in extracorporeal circuitry to suit the 
unique fetal physiology increase the possibility of future clinical applica- 
tion. (J THORAC CARDIOVASC SURG 1996;111:536-44) 
A lthough primary cardiac morphogenesis is com- plete by 8 weeks of intrauterine life, further 
development of the heart is substantially influenced 
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by fetal blood flow patterns.1 A structural abnormal- 
ity that develops during primary morphogenesis can 
alter intracardiac blood flow patterns and cause 
important secondary morphologic consequences. 
After birth, these secondary structural lesions may 
pose a more serious management problem than the 
primary lesion itself. With recent advances in ultra- 
sonic imaging, it is now possible to accurately diag- 
nose structural heart defects as early as 12 weeks of 
gestation.2, 3 Theoretically, if the primary lesion is 
corrected in utero the secondary morphologic on- 
sequences can be avoided. 4 
Many potentially useful surgical interventions in 
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the fetus will need extracorporeal support. Because 
the fetus has a unique cardiovascular physiology, 
standard techniques of neonatal cardiopulmonary 
bypass need to be modified to preserve the milieu of 
the fetal-placental-maternal unit. Previous work 5-1° 
has shown the feasibility of fetal cardiac bypass, but 
this work also identified the physiologic barriers to 
successful fetal cardiac bypass. Postbypass placental 
dysfunction is the most significant barrier, and a 
number of the mechanisms involved in this dysfunc- 
tion have been identified. The stimuli causing pla- 
cental dysfunction are fetal stress, extracorporeal 
surfaces, priming substances, and flow characteris- 
tics. In our laboratory the beneficial effects of min- 
imizing fetal stress and blocking placental dysfunc- 
tion by inhibiting prostaglandin synthesis have been 
demonstrated. 1113 Our present focus is to study the 
effects of extracorporeal circuitry on fetal metabo- 
lism, placental hemodynamics, and long-term fetal 
outcome. A customized fetal bypass circuit was 
designed incorporating an axial pump 14 (He- 
mopump device, Johnson & Johnson Interventional 
Systems, Rancho Cordova, Calif.) into the venous 
cannula. Short-term bypass studies were performed 
with this new circuit and the results were compared 
with results obtained with conventional roller pump 
circuits. Placental function and fetal hemodynamics 
were preserved significantly better with this new 
circuit even without pharmacologic blunting of the 
fetal stress response or inhibition of prostaglandin 
synthesis. In the present study long-term fetal out- 
come was investigated with this newly designed 
bypass circuit. 
Methods 
Surgical preparation. Nine mixed-breed pregnant ewes 
(at 124 -+ 1.1 days of gestation; term = 145 days) were 
fasted for 24 hours before the study. On the day of the 
study the ewe was premedicated with ketamine (10 mg/kg 
intramuscularly) and buprenorphine (0.01 mg/kg intra- 
muscularly). Epidural spinal anesthesia was achieved with 
4 ml of 1% tetracaine hydrochloride. The ewe was then 
placed supine on the operating table and lightly fastened. 
The maternal anesthesia was maintained with intravenous 
ketamine infusion at a rate of 3 to 5 mg/kg per hour. A 
16-gauge central venous catheter was placed into the 
jugular vein. Maternal heart rate, arterial pressure, and 
central venous pressure were monitored and lactated 
Ringer's olution was administered ata rate of 4 ml/kg per 
hour. 
A midline laparotomy was performed and the uterus 
was exposed. By gentle palpation the number and orien- 
tation of the fetuses were determined (single fetus, n = 5; 
twins, n - 4). A hysterotomy was made over the fetal chest 
and the fetal forelimbs were extracted. Fetal anesthesia 
was achieved with ketamine (10 mg/kg intramuscularly). 
In addition succinylcholine hydrochloride (2 mg/kg intra- 
muscularly) was administered to prevent fetal breathing 
movements. After a few minutes the fetus was gently 
supinated to expose the sternum. A 20-gauge central 
venous catheter was placed into the jugular vein to 
monitor the fetal central venous pressure and to admin- 
ister intravenous fluids. Midline fetal sternotomy was 
performed and a 20-gauge arterial catheter was placed 
into the right internal thoracic artery and advanced into 
the subclavian artery. Pericardiotomy was performed and 
the heart was exposed. Purse-string sutures (5-0 Prolene 
p01ypropylene, Ethicon, Inc., Somerville, N.J.) were 
placed on the main pulmonary artery (n = 5) or the 
ascending aorta (n = 4) and on the superior vena cava just 
proximal to its junction with the right atrium. Fetal 
cardiac bypass was performed according to the protocol 
outlined herein. 
After cessation of the bypass, hemostasis was secured, 
all cannulas and catheters were removed, and the fetal 
chest was closed. The hysterotomy was closed after re- 
placement of the amniotic fluid with warm saline solution 
and administration of antibiotics (2 million units of pen- 
icillin G procaine and 100 mg of gentamicin sulfate). The 
maternal laparotomy was repaired and the ewe was re- 
turned to the pen. All animals received standard postop- 
erative care. Antibiotics (2 million units of penicillin G 
procaine and 100 mg of gentamicin sulfate) were admin- 
istered intravenously to the ewe during the operation and 
intramuscularly daily thereafter for 5 days. The ewes were 
allowed to progress to term and deliver normally. 
Experimental protocol 
Extracorporeal circuit. The circuit is illustrated in Fig. 1. 
The Hemopump device I4 is a miniature axial flow pump. 
It was incorporated into the proximal end of the venous 
cannula and the drive cable was brought out through one 
limb of the Y connector. A short segment of a quarter- 
inch polyvinyl tubing containing an in-line flow probe was 
attached to the other limb of the Y connector. To this 
tubing the arterial cannula was connected, thereby form- 
ing a closed loop system. The total capacity of the circuit 
was 14 to 16 ml. Thus no priming was necessary. The 
circuit was filled with fetal blood at the time of cannula- 
tion. 
Fetal cardiac bypass. Fetal weight was estimated on the 
basis of the gestational age by means of a standard 
nomogram. 15 A 300 U/kg dose of heparin was given 
intravenously tOthe fetus via the superior vena cava. The 
right atrium was cannulated via the superior vena cava 
with a 16F angled-tip venous cannula (DLP, a division of 
Medtronics, Grand Rapids, Mich.) and the bypass circuit 
was filled with fetal blood and deaired. A 12F arterial 
cannula (Electro-Catheter Corp. Rahway, N.J.) was 
placed in the main pulmonary artery (n = 5) or the 
ascending aorta (n -- 4) and was filled with fetal blood and 
deaired. The arterial and venous componen~ of the 
circuit were connected and the bypass was initiated. Pump 
flows were continuously monitored with an in-line ultra- 
sonic flow probe (Transonic Systems, Inc., Ithaca, N.Y.). 
Bypass was continued for 30 minutes. Fetal blood gases 
were measured immediately before bypass, at 15 minuteS 
of bypass, and immediately after cessation of bypass. 
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Fig. 1. Fetal cardiac bypass circuit: A, Arterial cannula; 1), drive cable; F, flow probe;/4, Hemopump 
device14; M, electromagnet; T, Y connector; V,, venous cannula. 
Blood samples for fetal arterial blood gases were drawn 
from the subclavian artery. Fetal hemoglobin concentra- 
tion and oxygen saturation were estimated before and 
after bypass. After the discontinuation of bypass and 
decannulation, hemostasis was secured, all catheters were 
removed, and the fetal sternotomy was closed. 
Data acquisition. Fetal and maternal systemic arterial 
pressures and fetal and maternal central venous pressures 
were measured with Statham P23Db pressure transducers 
(Statham Instruments, Division of Viggo-Spectramed, 
Inc., Critical Care Div., Oxnard, Calif.). Mean pressures 
were obtained by electrical integration. Heart rate was 
measured by a cardiotachymeter riggered from the phasic 
systemic arterial pressure pulse wave. Pump flow was 
measured on an ultrasonic flowmeter (Transonic). All 
hemodynamic variables were continuously recorded on a 
Gould multichannel lectrostatic recorder (model TAl l ,  
Gould Inc., Cleveland, Ohio). Systemic arterial blood 
gases and pH were measured on a Corning 158 pH/blood 
gas analyzer (Corning Medical and Scientific, Medfield, 
Mass.). Hemoglobin concentration and oxygen saturation 
were measured by a hemoximeter (model OSM 2, Radi- 
ometer A/S, Copenhagen, Denmark). 
Neonatal lamb study. At birth the lambs were weighed 
and clinically examined by an experienced veterinarian. At 
i week of age the lambs were weighed again and clinically 
examined. The lambs were then put to death with an 
overdose Of pentobarbitol and an autopsy was performed. 
All body cavities and viscera were examined. The brain, 
heart, liver, spleen, both lungs, and both kidneys were 
harvested and stored in 10% formaldehyde solution for 
later pathologic examination. 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). The experimental 
protocol was approved by the Committee for Animal Care 
at the University of California San Francisco. 
Pathology. Gross arid microscopic examination of the 
organs was performed by a veterinary pathologist (all 
organs), a cardiac pathologist (all organs except the 
brain), and a neuropathologist (only brains). Serial trans- 
verse sections (about 0.5 cm thick) of the hearts were 
examined for any gross abnormality. Representative s c- 
tions were taken for microscopic examination from the 
right ventricular free wall, left ventricular free wall, and 
the interventricular septum. The brains were sectioned 
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Table I. Fetal bypass data and outcome 
No. of pH Pco 2 Po 2 
fetuses pH* pH? pH$ change Pc02* Pc02~ Pc02¢ change P02* P02~ P028 change PF Outcome 
Single 7.38 7.34 7.29 0.09 42.10 43.20 45.00 2.90 24.00 23.10 20.10 3,90 300 Alive 
Single 7.39 7.35 7.29 0.10 35.20 42.10 48.10 12.90 19.60 19.20 18.20 1.40 360 Alive 
Twins 7.37 7.35 7.30 0.07 45.00 49.40 51.90 6.90 22.60 21.60 20.70 1.90 300 Alive 
Single 7.35 7.30 7,21 0.14 45.90 54.20 60.00 14.10 21.60 17.20 16.00 5.60 324 Dead 
Twins 7.41 7.36 7.28 0.13 39.20 50.10 52.90 13.70 24.10 23.60 20.90 3,20 300 Alive 
Single 7.43 7.40 7.35 0.08 41.40 43.20 48.90 7.50 26.90 24.10 21.30 5,60 271 Alive 
Twins 7.47 7.42 7.40 0.07 40.30 40.80 45.60 5.30 31.20 28.50 23,10 8,10 330 Alive 
Twins 7.42 7.38 7.32 0.10 42.00 43.10 44.00 2.00 25.70 22.90 21.80 3,90 375 Alive 
Single 7.37 7.33 7.29 0.08 47.60 48.10 52.50 4.90 22.40 23.70 22.10 0,30 324 Alive 
Mean 7.40 7.36 7.30 0.10 42.08 46.02 49.88 7.80 24.23 22.66 20.47 3,77 320.49 
SD 0.04 0.04 0.05 0.03 3.76 4.56 5.04 4.66 3.40 3.19 2.17 2.42 32.24 
Changes in pH, carbon dioxide tension (Pco2), and oxygen tension (Po2) are calculated as the difference between the prebypass and postbypass parameters. 
The change in pH, Pco2, and Po2 did not correlate with fetal death (linear regression; adjusted R2 = 0.235; p - 0.263. Pump flow (PF) is expressed as 
millihters per kilogram of estimated fetal weight. SD, Standard eviation. 
*Before bypass. 
1-At 15 minutes of bypass. 
~:Immediately after bypass. 
(0.5 cm thick) in accordance with the clinical method and 
examined for any gross abnormality. Representative s c- 
tions were then taken from the cerebral cortex (motor), 
basal ganglia, and cerebellum for microscopic examina- 
tion. Similarly, the lungs, liver, spleen, and kidneys were 
examined for any gross abnormalities. Representative 
sections were then taken from the upper and lower lobes 
of both lungs, from both lobes of the liver, from the 
spleen, and from both kidneys. All the representative 
sections were stained with hematoxylin and eosin stain by 
standard techniques. 
Data analysis. Fetal blood gas parameters, pump flows, 
and animal weights are expressed as mean + standard 
deviation. The absolute change in pH, carbon dioxide 
tension, and oxygen tension during bypass was calculated 
as the difference between the immediate prebypass and 
immediate postbypass pH, carbon dioxide tension, and 
oxygen tension. This change in blood gas parameters was 
correlated with the fetal outcome by linear regression 
analysis (SPSS for Windows, version 6.01; SPSS Inc., 
Chicago, Ill.). 
Results 
Bypass data. Fetal bypass data are summarized 
in Table I. The absolute difference in prebypass and 
postbypass blood pH, carbon dioxide tension, and 
oxygen tension did not correlate with fetal death 
(linear regression; adjusted R 2 = 0.235; p = 0.263). 
Long-term survival. Eight of the nine fetuses 
(88%) progressed to term and were delivered nor- 
mally. All twin fetuses (n = 4) including the unoper- 
ated twin were delivered normally. Of the five single 
fetuses, one was stillborn 4 days after fetal bypass. At 
autopsy there was no evidence of bleeding into the 
body cavities or any gross evidence of organ damage. 
Postnatal course. The weight of the lambs (n = 
8) at birth and at 1 week of age (n = 7) was within 
normal limits for the lambs (Fig. 2). All animals 
appeared healthy with well-healed sternotomy scars. 
One lamb died 24 hours after birth of blunt trauma 
after being trampled. The other seven lambs thrived 
and progressed normally until 1 week of age, when 
they were studied. 
Pathology results. Myocardial architecture was 
essentially normal (Fig. 3) with no evidence of 
thromboembol ic or hemorrhagic lesions and no 
evidence of hypoxic damage. In the fetus that died 
4 days after bypass, the cerebral cortex showed 
mild to moderate neuronal oss (Fig. 4) and mild 
astrogliosis. Both are suggestive of tissue injury 
from hypoxia or low perfusion. In all survivors, the 
cerebral cortex (Fig. 5) and basal ganglia were 
normal. The Purkinje neurons, which are sensitive 
to hypoxia, were normal in all the lambs (Fig. 6). 
No evidence of intracerebral or intraventricular 
hemorrhage was detected in any of the lambs or 
the stillborn fetus. The liver in the stillborn fetus 
showed evidence of mild venous congestion. Two 
survivors had a mild increase in glycogen content 
of the liver. In all the others the liver was essen- 
tially normal. All animals had normal pulmonary 
architecture. Evidence of mild pleural thickening 
was seen in three lambs. In the stillborn fetus the 
lung was immature with evidence of mild conges- 
tion. The spleen and kidneys did not show any 
evidence of hemorrhage, infarction, or hypoxie 
damage in any of the lambs. 
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Fig. 2. Weight of the study lambs (fetuses, n = 9; newborn, n = 8; 7 days old, n = 7) and normal ambs 
(n = 5). The growth of the lambs delivered after fetal cardiac bypass was similar to that of normal lambs. 
Fig. 3. Microscopic appearance (× 100) of the left ventricular f ee wall showing normal myocardial cells 
and fiber architecture. 
Discuss ion  
The sheep is an excellent model for studying fetal 
extracorporeal techniques. A wealth of information 
on basic fetal physiology is available, which provides 
an excellent background for evaluating the patho- 
logic responses that occur after fetal extracorporeal 
circulation. Additionally, inasmuch as the fetal 
sheep is about the size of the human fetus, critical 
technical issues can be appropriately assessed. 
Early studies s'6 of fetal extracorporeal circulation 
indicated that technical problems were easily solved, 
but the pathophysiologic responses of the fetal- 
placental-maternal unit to fetal extracorporeal cir- 
culation were challenging. The major obstacle to 
successful fetal extracorporeal circulation is that it 
directly causes increased placental vasoconstriction 
leading to the development ofplacental dysfunction. 
Another important issue was that the fetal response 
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Fig. 4. Microscopic appearance (x100) of a section from the cerebral cortex of a fetus that died after fetal 
cardiac bypass. Note the cortical neuronal loss, which is suggestive of hypoxia or low flow to the brain. 
Fig. 5. Microscopic appearance (×100) of cerebral cortex of a lamb that was subjected to fetal cardiac 
bypass as a fetus. No abnormalities were noted. 
to surgical stress led to cardiovascular instability and 
subsequent secondary placental dysfunction. 
When the direct effects of extracorporeal circula- 
tion on the placenta nd the fetal response to 
surgical stress were not addressed, fetuses urvived 
for only minutes to hours after fetal bypass. When 
these negative responses were carefully managed, 
fetal hemodynamics and placental function were 
significantly preserved. 11-13 With these techniques a 
40% fetal survival to term was achieved. 16 Although 
achieving fetal survival was an important advance, 
the overall outcome was still poor. We hypothesized 
that improvements in bypass circuitry might further 
improve the tolerance of the fetus to extracorporea! 
circulation. A new bypass circuit was designed with 
the incorporation of an in-line axial flow pump 
(Hemopump device) in the venous cannula. With 
this new circuit the extracorporeal surface was 
markedly reduced and, importantly, external prim- 
ing volume was completely avoided. Short-term 
studies 17 were performed comparing this circuit with 
the conventional circuit while at the same time 
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Fig. 6. Microscopic appearance (× 100) of a cerebellar section of a lamb (long-term survivor after fetal 
cardiac bypass). Note that the Purkinje neurons look normal. 
avoiding our previously developed techniques of 
blunting the stress response or blocking prostaglan- 
din synthesis. This study was designed in this fashion 
to isolate as much as possible the influence of the 
extracorporeal circuitry itself. Fetal cardiac bypass 
was performed via a midline sternotomy with exten- 
sive fetal instrumentation. This study showed that 
minimizing fetal extracorporeal circuitry and avoid- 
ing priming volume resulted in significant improve- 
ment in placental function. 
The present long-term study was then undertaken 
to determine the influence of these beneficial effects 
on long-term fetal survival. Eight (89%) of the 
fetuses urvived to term gestation and were deliv- 
ered normally. One fetus was aborted 4 days after 
fetal bypass. Autopsy was not suggestive of any 
definitive cause of death. Death may have been due 
to progression of placental dysfunction or to meta- 
bolic issues, which need to be addressed. After birth 
the progress of these lambs was observed for i week. 
One lamb died 24 hours later of blunt trauma 
caused by trampling. The remaining seven lambs 
grew normally with appropriate weight gain at 1 
week of age. 
The current study is significant in many ways. 
First, it demonstrates that survival to term can be 
achieved after transsternal, clinically applicable 
methods of bypass. Second, and more important, it
demonstrates that improvements in extracorporeal 
circuitry will significantly minimize the perturbation 
of the fetal-placental-uterine milieu after fetal car- 
diac bypass. 
It appears from our more recent studies that 
although pharmacologic management of fetal stress 
is undoubtedly important and inhibition of prosta- 
glandin synthesis protects the placenta, minimizing 
the stimuli (i.e., extracorporeal surfaces and priming 
substances) that initiate the pathophysiologic mech- 
anisms is much more important. In essence, the new 
bypass circuitry is preventive whereas the pharma- 
cologic management is not, but rather treats the end 
organ response. We believe the former approach to 
be much more sound. 
One critique of this circuit is that it is extremely 
simple. For example, it has no mechanism for 
preventing air embolism from the venous cannula- 
tion site if the venous line pressure becomes ubat- 
mospheric. This is a highly valid concern and nec- 
essary improvements are being further evaluated in 
our laboratory. With proper regulation of flows and 
aggressive intravenous fluid administration to the 
fetus, we did not encounter any observable air 
embolism during the 30-minute bypass period in any 
of the fetus. To confirm this, we examined all major 
organs and detected no evidence of thromboembolic 
and hypoxic damage in any of the survivors. The one 
fetus that was aborted 4 days after bypass showed 
evidence of mild to moderate cortical neuronal loss 
and astrogliosis. Both these findings are suggestive 
of low perfusion or hypoxic damage. Indeed they 
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probably could be the result of progressive hypoxia 
after bypass, which may have resulted in the death of 
this fetus. Of note, no hemorrhagic lesions were 
found in the brain. However,  the sheep is not a good 
model  for evaluation of cerebral  and intraventricu- 
lar b leeding because the germinal  matrix matures 
relatively early in the sheep fetus. 
in summary, this study shows that with improve- 
ments in extracorporeal  techniques favorable fetal 
survival to term is possible after fetal cardiac bypass. 
However,  the improved results may also be part ly 
due to better  understanding of the fetal -placental  
unit and general  experience with fetal surgical tech- 
niques. Fur ther  modif ications are necessary to make 
the bypass circuit more safe for possible clinical 
appl icat ion in the future. Also, cerebral  effects of 
bypass should be evaluated in a more appropr iate  
animal model.  
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Discuss ion 
Dr. Edward D. Verrier (Seattle, Wash.). This work is a 
continuum of the extensive basic science and clinical work 
originating from the University of California San Fran- 
cisco (UCSF) investigating fetal physiology and potential 
clinical fetal intervention. The key scientific advance 
promulgated by this investigation is the use of the small 
Hemopump device located in the venous cannula. With 
this approach, the priming volume of the circuit is small 
and the exposure of blood to the artificial surfaces is 
minimized. Eight of the nine fetuses progressed to deliv- 
ery and only one of the survivors had histologic evidence 
of organ injury. 
I have no specific questions for Dr. Reddy because I 
believe the work is essentially self-explanatory. This inno- 
vative technique appears to be step forward in improving 
the safety of cardiopulmonary bypass in fetuses. My 
questions are more philosophical, and I believe a discus- 
sion of where this productive area of research is headed 
might be of interest o a largely clinically oriented audi- 
ence. 
The sheep model has been very productive in all studies 
of fetal physiology, but it is significantly different from 
primates in terms of cardiovascular, placental, and mater- 
nal physiology. From an investigative standpoint, are we at 
the point at which nonhuman primate studies are indi- 
cated? Have there been significant improvements in toco- 
lytic therapy, which is one of the common limiting factors 
in human interventions? Have you thought about the cost 
of such research and some of the issues involved with that 
next step? 
Dr. Reddy. We have made substantial progress in terms 
of fetal cardiac research in sheep, and I agree that it is 
time now to examine some important issues in primates. 
We have performed initial studies in primates and the 
placental response to fetal extracorporeal circulation is 
identical to that in sheep. 
The cost of primate research is very highl one pregnant 
rhesus monkey costs about $3500. We are, however 
planning further work in primates because of the impor- 
tance of these studies. 
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A number of tocolytic agents have been examined by 
Dr. Harrison's group at UCSF. They have had some 
success in human beings with nitric oxide donors, espe- 
cially nitroprusside. They are currently investigating the 
agents more specific to the uterus, which have fewer 
systemic side effects. 
Dr. Verrier. Dr. Michael Harrison initiated the clinical 
fetal treatment program at UCSF more than 20 years ago. 
Initially there was great hope that fetal intervention would 
substantially improve the outcomes in congenital dia- 
phragmatic hernia, ureteral and urethral obstruction, hy- 
drocephalus, and some fetal tumors. A number of spec- 
tacular results have been obtained. However, in recent 
discussions with Dr. Harrison, I have learned that the 
indications for fetal intervention have significantly nar- 
rowed. The thrust Of their present research is focused on 
in utero immunologic molecular and genetic manipula- 
tion. No other clinical fetal treatment program has 
emerged elsewhere in the world. Are there lessons to 
learn from that experience? Cardiopulmonary bypass 
adds another complex variable to simple maternal and 
fetal transgression. 
Dr. Reddy. The concerns that you have raised are all 
very important. The rationale for fe[al intervention is 
based on the premise that if a defect is corrected in utero, 
the developing fetus will have the remainder of the 
gestation to recover and the secondary morphologic se- 
quelae will be prevented or minimized. The main stum- 
bling block has been premature delivery. The benefit of 
fetal surgery is lost if the fetus is delivered prematurely. 
Therefore prevention of premature labor by effective 
tocolytic therapy is an important area of investigation. 
Progress has been snow in the field of fetal surgery. 
However, the enthusiasm has not been dampened, be, 
cause at least three young investigators from various 
centers in the United States have visited our laboratory in 
the past year, and some from abroad continue to corre- 
spond with us and have started work in their centers. 
Dr. Verrier. Widespread use of echocardiography in 
high-risk pregnancies has identified congenital heart le- 
sions earlier. Many of these complex lesions can be 
diagnosed at 12 weeks' gestation, Lindsay Allen, who is 
one of the premier pediatric ardiologists in the world, 
from Great Ormond Street, London, has written and 
spoken extensively about he therapeutic options available 
to women whose fetuses have congenital heart disease. 
Her recommendation u equivocally is termination of the 
pregnancy, even for simple lesions like c0arctation of the 
aorta or pulmonary stenosis. Obviously this brings in 
ethical and other issues. Would you comment on other 
therapeutic options that would be available in the context 
of the economic issues involved in the treatment of such 
complex disease? 
Dr. Reddy. Termination of pregnancy as advocated by 
Dr. Allen is a highly debatable thical issue. I think this 
question should be answered not only by doctors but also 
by sociologists, philosophers, ethicists, economists, politi- 
cians, and law makerS. 
Regarding other modalities Of therapy for fetal cardiac 
lesions, certain important areas require further careful 
investigation. For example, if interventional cardiologists 
can gain safe access to the fetal heart, lesions like critical 
stenosis and restricted foramen ovale will be amenable to 
minimally invasive intervention. In addition, fetal molec- 
ular and genetic therapies may become a reality in the 
future. One area that we are investigating is induction of 
fetal immunotolerance for possible neonatal transplanta- 
tion in all cases of complex congenital heart disease. 
Research in the area  of fetal intervention, although 
expensive, deserves continued support because of the 
enormous potential benefits. 
Dr, Verrier. It is very important to realize that if we are 
able to alter the patterns of blood flow in utero, then the 
single-ventricle physiology very well may be avoided. The 
limiting factor in congenital heart disease is dealing with 
complex single-ventricle physiology. Thus this research 
maintains hope that we may be able to alter those patterns 
in utero with relatively simple interventions , and the type 
of work that has been continued at UCSF will help us 
reach that goal. 
Dr. Margaret Alien (Seattle, Wash.). Have you looked at 
bypass times that are longer than 30 minutes? Is there a 
limit to What you can get away with? 
Dr. Reddy. We have at the moment only evaluated up to 
30 minutes, but for acute studies we have performed 
bypass times up to 1 hour with good preservation of 
placental function with the use of this new circuit. We 
have not looked at the effect on survival yet. 
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